Keros Therapeutics (KROS)
NASDAQ:KROS
Want to see KROS full AI Analyst Report?
Keros Therapeutics (KROS) Ownership Overview
51.08% Insiders
18.56% Mutual Funds
0.87% Other Institutional Investors
16.12% ETFs
13.37% Public Companies and
Individual Investors
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 35.54% of the company’s stock is owned by Institutional Investors, 51.08% is owned by Insiders, and 13.37% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 20, 2026 | xxxxxxxxxxxxx | $77483 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $63324 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $113433 | |
Oct 17, 2025 | xxxxxxxxxxxxx | $84975125 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $855120 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $305400 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,637,319 | Insider | 23.52% | 51,474,241 | |
| 4,637,319 | Insider | 23.52% | 51,474,241 | |
| 2,189,882 | Institution | 11.11% | 24,307,690 | |
| 1,135,841 | Institution | 5.76% | 12,607,835 | |
| 1,054,517 | Institution | 5.35% | 11,705,139 | |
| 808,401 | Institution | 4.10% | 8,973,251 | |
| 480,615 | Institution | 2.44% | 5,334,827 | |
| 440,708 | Insider | 2.24% | 4,891,859 | |
| 368,847 | Institution | 1.87% | 4,094,202 | |
| 297,180 | Institution | 1.51% | 3,298,698 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 808,401 | Institution | 4.10% | 8,973,251 | |
| 480,615 | Institution | 2.44% | 5,334,827 | |
| 368,847 | Institution | 1.87% | 4,094,202 | |
| 297,180 | Institution | 1.51% | 3,298,698 | |
| 218,423 | Institution | 1.11% | 2,424,495 | |
| 171,150 | Institution | 0.87% | 1,899,765 | |
| 168,517 | Institution | 0.85% | 1,870,539 | |
| 162,294 | Institution | 0.82% | 1,801,463 | |
| 143,853 | Institution | 0.73% | 1,596,768 | |
| 117,452 | Institution | 0.60% | 1,303,717 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 679,974 | Institution | 3.45% | 7,731,304 | |
| 595,316 | Institution | 3.02% | 6,572,289 | |
| 241,921 | Institution | 1.23% | 2,685,323 | |
| 217,395 | Institution | 1.10% | 2,400,041 | |
| 145,517 | Institution | 0.74% | 1,654,528 | |
| 143,387 | Institution | 0.73% | 1,582,992 | |
| 137,498 | Institution | 0.70% | 1,563,352 | |
| 94,451 | Institution | 0.48% | 1,073,908 | |
| 79,563 | Institution | 0.40% | 904,631 | |
| 65,248 | Institution | 0.33% | 741,870 |
FAQ
Who Owns Keros Therapeutics (KROS)?
According to the latest TipRanks data, approximately 0.87% of the company's stock is held by institutional investors, 51.08% is held by insiders, and 13.37% is held by retail investors.
What percentage of Keros Therapeutics (KROS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.87% of Keros Therapeutics (KROS) stock is held by institutional investors.
What percentage of Keros Therapeutics (KROS) stock is held by retail investors?
According to the latest TipRanks data, approximately 13.37% of Keros Therapeutics (KROS) stock is held by retail investors.
Who owns the most shares of Keros Therapeutics (KROS)?
Tomer Kariv owns the most shares of Keros Therapeutics (KROS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.